Healthcare Value Capital as of Sept. 30, 2021
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 23 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS Put Option (ALKS) | 12.2 | $6.2M | 200k | 30.84 | |
| Pfizer (PFE) | 10.6 | $5.4M | 125k | 43.01 | |
| Gilead Sciences (GILD) | 8.3 | $4.2M | 60k | 69.85 | |
| Glaxosmithkline Sponsored Adr | 7.5 | $3.8M | 100k | 38.21 | |
| Amryt Pharma Sponsored Ads | 6.0 | $3.0M | 250k | 12.09 | |
| Merck & Co (MRK) | 5.9 | $3.0M | 40k | 75.10 | |
| Astrazeneca Sponsored Adr (AZN) | 5.9 | $3.0M | 50k | 60.06 | |
| Bristol Myers Squibb (BMY) | 5.8 | $3.0M | 50k | 59.18 | |
| Proshares Tr Ultrapro Short S Call Option | 5.2 | $2.6M | 150k | 17.54 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 5.2 | $2.6M | 200k | 13.06 | |
| Clovis Oncology | 4.4 | $2.2M | 500k | 4.46 | |
| Tyme Technologies | 4.1 | $2.1M | 2.0M | 1.03 | |
| Antares Pharma | 3.6 | $1.8M | 500k | 3.64 | |
| Proshares Tr Ultrapro Sht Qqq Call Option | 3.4 | $1.7M | 200k | 8.63 | |
| Proshares Tr Ii Ultra Vix Short Call Option | 2.4 | $1.2M | 50k | 24.56 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 2.0 | $1.0M | 200k | 5.10 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $907k | 5.0k | 181.40 | |
| Greenlane Hldgs Cl A | 1.6 | $830k | 350k | 2.37 | |
| Vyne Therapeutics | 1.1 | $556k | 400k | 1.39 | |
| Adamas Pharmaceuticals | 1.0 | $491k | 100k | 4.91 | |
| Gamida Cell SHS | 0.8 | $392k | 100k | 3.92 | |
| DURECT Corporation | 0.6 | $320k | 250k | 1.28 | |
| Proshares Tr Ii Vix Sh Trm Futrs Call Option | 0.6 | $285k | 13k | 22.80 |
